VRP.L Share News (VRP)

Verona Pharma Completes Patient Enrolment For RPL554 Studies

Verona Pharma: First Patients Dosed In RPL554 Combination Study

Verona Pharma rallies on positive drug study results

(ShareCast News) - Shares in Verona Pharma rallied after it announced positive headline data from the third and final part of a clinical study on its RPL554 drug for the treatment of chronic obstructive pulmonary disease. The drug development company said the primary objective of this part of the st

Verona Pharma Shares Up 10% On Good RPL554 Study Results

Verona Pharma plunges as interim loss widens

(ShareCast News) - Shares in Verona Pharma plunged over 12% early on Tuesday, after the pharmaceutical company posted a wider interim pre-tax loss. The London-listed company, which attributed the wider loss to an increase in research and development spending, saw its pre-tax loss for the six months

Verona Pharma Loss Widens On Higher Research And Development Spending

LONDON MIDDAY BRIEFING: Greece Remains Optimistic For Debt Deal

WINNERS & LOSERS: Petra Diamonds Loses Sparkle On Lower Quality Stones

Verona Pharma to launch secondary listing in Germany

AIM-listed drug developer Verona Pharma has carried out a second listing in Germany. The move will be a way of further raising its profile within continental Europe and to increase the potential for investors in German-speaking Europe to trade in the company's shares, it said. The group will be lis

Verona Pharma Takes Secondary Listing In Germany (ALLISS)

Verona Pharma Begins Phase 2A Dose-Finding Trial Of RPL554 In Asthma

LONDON MORNING BRIEFING: Royal Mail Falls, RBS Gains On UK Govt Moves

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead